191 77 (Capecitabine 500 mg)
Pill with imprint 191 77 is Peach, Capsule-shape and has been identified as Capecitabine 500 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 191 77
Capecitabine
- Imprint
- 191 77
- Strength
- 500 mg
- Color
- Peach
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7474 | Teva Pharmaceuticals USA, Inc. |
| 42291-0191 (Discontinued) | AvKare, Inc. |
More about capecitabine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (45)
- Drug images
- Pricing & coupons
- En español
- Drug class: antimetabolites
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.